Roche Announces Shipments of New Supplies of Children's Tamiflu® in the U.S.
December 01, 2009
August 31, 2009
FDA APPROVES VALCYTE® (VALGANCICLOVIR HYDROCHLORIDE) TO PREVENT CYTOMEGALOVIRUS (CMV) DISEASE IN PEDIATRIC PATIENTS WHO RECEIVE HEART OR KIDNEY TRANSPLANTS
June 26, 2009
ROCHE DISCONTINUES AND PLANS TO DELIST ACCUTANE IN THE U.S.
June 09, 2009
ROCHE TO COMMENCE PHASE III TRIALS WITH INNOVATIVE TREATMENT DESIGNED TO LOWER CARDIOVASCULAR RISK IN DIABETES PATIENTS WITH RECENT HEART ATTACK
June 09, 2009
DATA DEMONSTRATED ACTEMRA® (TOCILIZUMAB) SIGNIFICANTLY INHIBITED PROGRESSION OF STRUCTURAL JOINT DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS
June 08, 2009
ROCHE SYMPOSIUM SHOWCASES ACCOMPLISHMENTS OF NEXT GENERATION OF CHEMISTS
June 04, 2009
ACTEMRA® (TOCILIZUMAB) STUDIES TO BE FEATURED AT THE EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) CONGRESS
- © 2012 Hoffmann-La Roche Inc.
-
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.